Proteomic Study of Plasma from Moderate Hypercholesterolemic Patients
- 2 August 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 5 (9) , 2301-2308
Abstract
Proteomics is a technology to detect and identify several proteins and their isoforms in a single sample. We used proteomics to analyze modifications in the protein map of plasma after simvastatin treatment of moderate hypercholesterolemic patients. Plasma from hypercholesterolemic patients (n = 9) was compared before and after 12 weeks of simvastatin treatment (40 mg/day). Patients with similar cardiovascular risk factors were used as controls (CR group). By using two-dimensional electrophoresis and mass spectrometry, we identified the different protein isoforms. The plasma expression of three fibrinogen gamma chain isoforms (FGG) was enhanced, whereas the expression of two isoforms of the fibrinogen beta chain (FGB) was reduced in the hypercholesterolemic patients compared with the CR group. The expression of apolipoprotein A-IV and three haptoglobin isoforms was higher in hypercholesterolemic patients. Simvastatin treatment modified the plasma expression of FGG chain isoform 1, FGB chain isoforms 1 and 2, vitamin D binding protein isoform 3, apo A-IV, and haptoglobin isoform 2. The modification of FGG chain isoform 1 and FGB chain isoforms 1 and 2 was positively correlated with total plasma cholesterol level. Proteomic analysis of plasma may help to know more in depth the molecular mechanism modified by simvastatin treatment. Keywords: hypercholesterolemia • plasma proteins • proteomics • simvastatinKeywords
This publication has 33 references indexed in Scilit:
- Simvastatin Regulates Myocardial Cytokine Expression and Improves Ventricular Remodeling in Rats after Acute Myocardial InfarctionCardiovascular Drugs and Therapy, 2005
- Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemiaThrombosis and Haemostasis, 2005
- Effect of simvastatin on endothelial function in cardiac syndrome X patientsThe American Journal of Cardiology, 2004
- Serum iron, infection and inflammation; effects on coronary riskScandinavian Cardiovascular Journal, 2004
- Statins and their role in vascular protectionClinical Science, 2003
- Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgeryAtherosclerosis, 1997
- Iron status and risk of cardiovascular diseaseAnnals of Epidemiology, 1997
- Protection Against Atherogenesis in Mice Mediated by Human Apolipoprotein A-IVScience, 1996
- Interaction of the vitamin D‐binding protein (groupspecific component) and its ligand 25‐hydroxyvitamin D3: Binding differences of the various genetic types disclosed by isoelectric focusingElectrophoresis, 1990
- Superoxide production and reducing activity in human platelets.Journal of Clinical Investigation, 1977